PRODUCT
Generate and test hypotheses for genes and pathways as potential drug targets or biomarkers, explore patient sub-segmentation, and more
Learn More
Triaxia’s Bioinformatic and Genomic capabilities
One Of A Kind Data
TriAxia is the only source in the world for this combination and scale of longitudinalty of clinical data for Pulmonary Hypertension and rare Interstitial Lung Diseases
Target Validation
Target validation and exploration of genetic components of disease pathophysiology
ID Biomarkers
Identification of biomarkers of responsiveness
Deep-Phenotyping
Sub-segmentation of patient populations via deep-phenotyping
Gene Scans
Gene scans of interest across an entire case/disease population
Industry standard QA processes across our molecular data supply chain
PRODUCTS
Powering the discovery, development, and deployment of new rare disease therapies
Real World Evidence + Advanced Analytics
Bespoke dataframes with HEOR services including advanced traditional and AI-enabled analytics
Learn MoreClinical Trial Support
Identify and recruit patients as clinical trial participants; create virtual control groups to replace or supplement trial controls
Learn More